BMP-1 inhibitors constitute a specific chemical class of compounds that have been studied and designed to selectively target and inhibit the activity of BMP-1, also known as Bone Morphogenetic Protein 1. BMP-1 is a metalloprotease enzyme responsible for processing and activating various extracellular matrix proteins and growth factors, including certain types of bone morphogenetic proteins (BMPs). These proteolytic activities are crucial for the regulation of tissue development and homeostasis. BMP-1 inhibitors are designed to interfere with the enzymatic function of BMP-1, potentially modulating the processing and activation of its substrates, which are involved in extracellular matrix remodeling and other cellular processes.
The chemical structures of BMP-1 inhibitors can vary, including peptide-based inhibitors and small-molecule compounds. Continued research in this chemical class may contribute to a deeper understanding of the role of BMP-1 in tissue development and extracellular matrix regulation, with potential implications in various biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
1,10-Phenanthroline | 66-71-7 | sc-255888 sc-255888A | 2.5 g 5 g | $23.00 $32.00 | ||
Certain phenanthroline-based compounds have shown inhibitory effects on BMP-1 and related enzymes, affecting the cleavage and activation of specific substrates. | ||||||
Ro 32-3555 | 190648-49-8 | sc-296277 | 10 mg | $413.00 | 2 | |
This is a small-molecule inhibitor of BMP-1 that has been explored for its potential to affect collagen and extracellular matrix synthesis. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
While primarily known as a calpain inhibitor, calpeptin has also shown some inhibitory effects on BMP-1 activity. | ||||||